Apeloa Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -14.55% vs -0.16% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -56.41% vs 26.51% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,319.40",
          "val2": "2,714.30",
          "chgp": "-14.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "155.10",
          "val2": "505.20",
          "chgp": "-69.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.20",
          "val2": "5.70",
          "chgp": "8.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "137.10",
          "val2": "314.50",
          "chgp": "-56.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "66.90%",
          "val2": "125.60%",
          "chgp": "-5.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.07% vs 8.61% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.32% vs 6.68% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,996.50",
          "val2": "11,418.10",
          "chgp": "5.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,606.40",
          "val2": "1,641.10",
          "chgp": "-2.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "35.50",
          "val2": "47.20",
          "chgp": "-24.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.10",
          "val2": "0.30",
          "chgp": "2,600.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,030.80",
          "val2": "1,055.30",
          "chgp": "-2.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "85.20%",
          "val2": "94.80%",
          "chgp": "-0.96%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

2,319.40

2,714.30

-14.55%

Operating Profit (PBDIT) excl Other Income

155.10

505.20

-69.30%

Interest

6.20

5.70

8.77%

Exceptional Items

0.10

-0.00

Consolidate Net Profit

137.10

314.50

-56.41%

Operating Profit Margin (Excl OI)

66.90%

125.60%

-5.87%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -14.55% vs -0.16% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -56.41% vs 26.51% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

11,996.50

11,418.10

5.07%

Operating Profit (PBDIT) excl Other Income

1,606.40

1,641.10

-2.11%

Interest

35.50

47.20

-24.79%

Exceptional Items

8.10

0.30

2,600.00%

Consolidate Net Profit

1,030.80

1,055.30

-2.32%

Operating Profit Margin (Excl OI)

85.20%

94.80%

-0.96%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 5.07% vs 8.61% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -2.32% vs 6.68% in Dec 2023

All Annual Results